Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
9-aminocamptothecin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2018

Triple Negative Breast Neoplasms
Breast Neoplasms
Neoplasms
Histone Deacetylase Inhibitors
Estrogen Receptors

Research Output 1992 2019

1 Citation (Scopus)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Rashkin, S. R., Chua, K. C., Ho, C., Mulkey, F., Jiang, C., Mushiroda, T., Kubo, M., Friedman, P. N., Rugo, H. S., McLeod, H. L., Ratain, M. J., Castillos, F., Naughton, M., Overmoyer, B., Toppmeyer, D., Witte, J. S., Owzar, K. & Kroetz, D. L., Mar 1 2019, In : Clinical Pharmacology and Therapeutics. 105, 3, p. 738-745 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Pharmacogenetics
Disease-Free Survival
Area Under Curve
Genome
Breast Neoplasms
1 Citation (Scopus)

Activated matriptase as a target to treat breast cancer with a drug conjugate

Rather, G. M., Lin, S. Y., Lin, H., Banach-Petrosky, W., Hirshfield, K., Lin, C. Y., Johnson, M. D., Szekely, Z. & Bertino, J., Jan 1 2018, In : Oncotarget. 9, 40, p. 25983-25992 10 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Breast Neoplasms
Antibodies
Heterografts
Pharmaceutical Preparations
91 Citations (Scopus)

Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Ravdin, P. M., Keane, M. M. & 10 othersGomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 111-121 11 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Gene Expression
Recurrence
Drug Therapy